Skip to content

Effectiveness of online platform Red Sinapsis monitoring in the quality of life of people with fibromyalgia

Effectiveness of online platform Red Sinapsis monitoring in the quality of life of people with fibromyalgia: A randomized controlled 1-year follow-up study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN58068252
Enrollment
71
Registered
2017-02-07
Start date
2013-07-03
Completion date
Unknown
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Nervous System Diseases Fibromyalgia

Interventions

Participants are randomised to one of two groups. Intervention group: Participants are telephoned and they are called in to the clinic to register them in the Red Sinapsis platform and assign them th

Sponsors

Universidad Autónoma de Madrid
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over 2. Diagnosed with Fibromyalgia following the American College of Rheumatology criteria 3. Have access to a computer

Exclusion criteria

Exclusion criteria: 1. Those who not have a computer or means to be followed up online 2. People with severe cognitive or mental disorders 3. Not providing informed consent to participate.

Design outcomes

Primary

MeasureTime frame
1. Perception of health status is assessed using the FIQ and SF-36 questionnaires at baseline, 6 and 12 months 2. Emotional state (anxiety and depression) is assessed using the FIQ and SF-36 questionnaires at baseline, 6 and 12 months

Secondary

MeasureTime frame
Degree of satisfaction with the platform usage is assessed using a survey designed for the purpose of this study at 12 months (intervention group only).

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026